Current Appointments & Affiliations
Associate Professor of Medicine
·
2025 - Present
Medicine, Cardiology,
Medicine
Member in the Duke Clinical Research Institute
·
2020 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Clinical Update on the Intersection of Lipoprotein(a) and Calcific Valve Disease
Journal Article Current Cardiovascular Risk Reports · December 1, 2025 Purpose of Review: To critically review the literature and summarize the available evidence to better understand the association of Lipoprotein(a) [Lp(a)] and calcific valve disease. Recent Findings: Serum Lp(a) is a causal and independent biomarker associ ... Full text CiteTraditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIV.
Journal Article JACC Adv · December 2025 BACKGROUND: Evaluation of nonvalvular atrial fibrillation/atrial flutter (NVAF) in under-represented racial and ethnic minority groups (UREGs) living with HIV has not been adequately studied. OBJECTIVES: The purpose of this study was to describe the incide ... Full text Link to item CiteNot All Prognostic Tools Are Equal: A Sex-Specific Approach to ASCVD Primary Prevention.
Journal Article Circ Cardiovasc Imaging · December 2025 Full text Link to item CiteRecent Grants
MK-0616
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme LLC. · 2024 - 2030A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) OCEAN(a)-Outcomes- Olpasiran trials
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2023 - 2028V-INCLUSION
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2024 - 2027View All Grants
Education, Training & Certifications
Wake Forest University, School of Medicine ·
2013
M.D.